Results 141 to 150 of about 2,657,498 (292)

Detection of renal tubular transporter proteins in canine urinary extracellular vesicles using liquid chromatography–tandem mass spectrometry

open access: yesVeterinary Clinical Pathology, EarlyView.
Abstract Urinary extracellular vesicles (UEVs) are membranous particles that carry renal tubular transporter proteins. Here, we evaluate whether selected renal tubular transporter proteins can be detected in UEVs isolated from small volume (1–5 mL) canine urine samples of healthy dogs and canine patients with elevated circulating parathyroid hormone ...
L. J. McGravey   +2 more
wiley   +1 more source

Reversal of uremic tumoral calcinosis by optimization of clinical treatment of bone and mineral metabolism disorder

open access: yesBrazilian Journal of Nephrology
Tumoral calcinosis is an uncommon type of extraosseous calcification characterized by large rubbery or cystic masses containing calcium-phosphate deposits. The condition prevails in the periarticular tissue with preservation of osteoarticular structures.
Mariana Espiga Maioli   +4 more
doaj   +1 more source

Osteitis Fibrosa Cystica; A Forgotten Manifestation of Secondary Hyperparathyroidism Due to End-Stage Renal Disease: A Case Report

open access: yesInternational Medical Case Reports Journal, 2022
Semir Abdi Usmael,1 Sisay Molla Ansa,1 Derejie Woldesilasie Tufa2 1Department of Internal Medicine, Haramaya University, College of Health and Medical Science, Harar, Ethiopia; 2Department of Radiology, Haramaya University, College of Health and Medical ...
Usmael SA, Ansa SM, Tufa DW
doaj  

Secondary hyperparathyroidism in patient with type 2 diabetes and stages 3–4 chronic kidney disease

open access: yesСахарный диабет, 2018
Secondary hyperparathyroidism is an early complication of chronic kidney disease, with increasing severity as the glomerular filtration rate decreases and characterized by a progressive increase in parathyroid hormone and growth of the parathyroid glands.
Lilit V. Egshatyan   +1 more
doaj   +1 more source

Metastatic pulmonary calcification [PDF]

open access: yes, 2016
Metastatic pulmonary calcification (MPC) may develop in patients with secondary hyperparathyroidism, related to end-stage renal disease (ESRD).1 The histologic pulmonary findings show calcium deposition in the lung interstitium, alveolar septa and ...
Baskin, Mark Harold   +2 more
core  

Molecular pathophysiology of chronic kidney disease–mineral and bone disorder: Focus on the fibroblast growth factor 23–Klotho axis and bone turnover dynamics

open access: yesExperimental Physiology, EarlyView.
Abstract Chronic kidney disease–mineral and bone disorder (CKD‐MBD) is a major complication of chronic kidney disease (CKD), characterized by disruptions in mineral metabolism, abnormal bone turnover and vascular calcification, which collectively increase the risk of fractures and cardiovascular disease.
Alief Waitupu   +4 more
wiley   +1 more source

Ferric Carboxymaltose (FCM)–Associated Hypophosphatemia (HPP): A Systematic Review

open access: yesAmerican Journal of Hematology, Volume 100, Issue 5, Page 840-846, May 2025.
ABSTRACT Background Since 2015, ferric carboxymaltose (FCM), an intravenous (IV) iron formulation used for treating iron deficiency anemia (IDA), has been associated with an increasing number of reported hypophosphatemia (HPP) cases. Information on HPP clinical manifestations and incidence has not been reviewed.
Joseph Magagnoli   +4 more
wiley   +1 more source

Understanding and Managing Infusion Reactions and Hypophosphataemia With Intravenous Iron—A Nurses' Consensus Paper

open access: yesNursing Open, Volume 12, Issue 4, April 2025.
ABSTRACT Aim To provide evidence‐based guidance on practical aspects and potential safety concerns (infusion reactions and hypophosphataemia) related to the use of intravenous iron from a nursing perspective. Design A modified Delphi consensus method.
Aileen Fraser   +5 more
wiley   +1 more source

Zoledronic acid increases spine bone mass and prevents hip bone loss after bariatric surgery: a randomized placebo‐controlled study

open access: yesObesity, Volume 33, Issue 4, Page 659-670, April 2025.
Abstract Objective The aim of this study was to investigate the effects of zoledronic acid for the prevention of bone loss after bariatric surgery. Methods In this randomized, double‐blinded study, 59 patients undergoing Roux‐en‐Y gastric bypass or sleeve gastrectomy (mean [SD], age: 48.9 [6.3] years, BMI: 42.3 [5.3], 73% female) were randomly assigned
Søren Gam   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy